LMT•October 17, 2026 at 2:35 PM UTCCapital Goods

Lockheed Martin's $230B Backlog Reiterated, But Quality Concerns Linger

Read source article

What happened

The Motley Fool article highlights Lockheed Martin's record $230 billion backlog, with growth concentrated in the high-margin Missiles and Fire Control segment, signaling strong future revenue. This aligns with the company's Q2 2026 filing, which showed backlog at $230.4 billion, up from $193.6 billion six months earlier, primarily driven by a $35 billion multi-year THAAD contract. However, the backlog's composition is narrow: missile backlog surged to $87.9 billion while Aeronautics backlog declined to $54.4 billion, and the company continued to record unfavorable profit adjustments on F-16, C-130, and other programs. The article does not address these execution risks or the concentration of growth in one large undefinitized action, which tempers the bullish signal for near-term operating quality. Overall, the news reinforces backlog strength already captured in the stock price but provides no new evidence of clean earnings conversion.

Implication

The record backlog underscores Lockheed's competitive moat, but the current valuation at 21.4x earnings already reflects much of the missile upside. The key to unlocking further gains is conversion quality: a funded PAC-3 MSE award under final FY2026 appropriations and sustained MFC margin above 14%, while Aeronautics stops incurring charges. Until those proof points appear, risk-reward is balanced at best, and pullbacks toward the $545 attractive entry would offer a better margin of safety. Investors should monitor the next quarterly filing for any new program charge or slippage in missile award cadence, as those would undermine the backlog's earnings quality.

Thesis delta

The news does not alter the thesis; it confirms the strong backlog already disclosed in Q2. However, the concentration of growth in MFC (specifically THAAD) and ongoing Aeronautics charges remain the critical offsetting factors. The investment stance remains WAIT at current prices, with a preference for entry near $545 and re-assessment after the next quarterly report or funded PAC-3 award.

Confidence

High